Healthcare -
Biotechnology - NASDAQ - US
$ 54.4243
4.44 %
$ 3.37 B
Market Cap
69.0
P/E
PTGX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities PTGX - Protagonist Therapeutics, Inc.
-299 M
LAST VALUE
-106.74%
2 YEAR CAGR
-41.01%
5 YEAR CAGR
-99.56%
10 YEAR CAGR